You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium-glucose co-transporter-2 (SGLT2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation Trial (Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor, Rhythm control and anticoagulation)

Not yet recruiting
  • Atrial Fibrillation
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Rhythm control and anticoagulation
  • (no location specified)
Aug 14, 2023

Healthy Volunteers Trial run by the NIDDK (Placebo, Canagliflozin)

Completed
  • Healthy Volunteers
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Heart Attack, Enlarged Heart Trial in Minneapolis (Dapagliflozin, Placebo)

Recruiting
  • Heart Attack
  • Enlarged Heart
  • Minneapolis, Minnesota
    Minneapolis Heart Institute Foundation
Aug 4, 2022

SGLT2-I Use in DFUD: a Delphi Study

Not yet recruiting
  • Diabetic Foot Ulcer
  • eDelphi method
  • (no location specified)
Aug 14, 2023

SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

Recruiting
  • Coronary Artery Disease
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Shah Alam, Selangor, Malaysia
    Institute for Clinical Research, National Institutes of Health,
Nov 9, 2023

(NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
  • (no location specified)
May 22, 2023

Heart Failure, Sleep Disordered Breathing Trial in New York (Dapagliflozin, WatchPat)

Not yet recruiting
  • Heart Failure
  • Sleep Disordered Breathing
  • New York, New York
    Vivian and Seymour Milstein Family Heart Center
Mar 8, 2022

Heart Failure With Reduced Ejection Fraction Trial in Chicago (SGLT2i, No SGLT2i)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Chicago, Illinois
    University of Chicago
Nov 11, 2022

Acute Pancreatitis in Type 2 Diabetes Mellitus Treated With

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • empagliflozin
  • Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim International GmbH
Aug 19, 2022

Metabolic Syndrome, Type 2 Diabetes, Obesity Trial in Perth (Empagliflozin Oral Tablet [Jardiance], Placebo Oral Tablet)

Recruiting
  • Metabolic Syndrome
  • +2 more
  • Empagliflozin Oral Tablet [Jardiance]
  • Placebo Oral Tablet
  • Perth, Western Australia, Australia
    Royal Perth Hospital
Sep 23, 2021

Acute Decompensated Heart Failure Trial in Chicago (SGLT2i, No SGLT2i)

Not yet recruiting
  • Acute Decompensated Heart Failure
  • Chicago, Illinois
    University of Chicago
Jun 10, 2022

Lupus Nephritis Trial in Alexandria (Dapagliflozin 10mg Tab orally once daily)

Not yet recruiting
  • Lupus Nephritis
  • Dapagliflozin 10mg Tab orally once daily
  • Alexandria, Egypt
    Ain Shams University
Oct 27, 2023

SGLT-2 Inhibitors in T2DM and Moderate to Severe Liver Fibrosis

Completed
  • Type2diabetes
    • New Delhi, Delhi, India
      Fortis CDOC Hospital
    Jul 14, 2023

    Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral

    Not yet recruiting
    • Acute Kidney Injury
    • +2 more
    • Dapagliflozin 10 MG Oral Tablet [Farxiga]
    • Placebo
    • Amsterdam, Netherlands
    • +5 more
    Oct 18, 2022

    Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Trial in Toronto

    Not yet recruiting
    • Peritoneal Dialysis Complication
    • +4 more
    • Empagliflozin 25 MG
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Jan 27, 2023

    Type 2 Diabetes Trial in Seoul (TZD group, SGLT-2 group)

    Completed
    • Type 2 Diabetes Mellitus
    • TZD group
    • SGLT-2 group
    • Seoul, Korea, Republic of
      Division of Endocrinology and Metabolism, Department of Internal
    May 3, 2021

    Empagliflozin in Type 2 Diabetes Population With and Without

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Durham, North Carolina
      Duke Clinical Research Institute
    Aug 8, 2022

    Heart Failure, Type 2 Diabetes Trial in Dundee (Empagliflozin 25mg, Placebo oral capsule, Frusemide)

    Completed
    Has Results
    • Heart Failure
    • Type 2 Diabetes Mellitus
    • Empagliflozin 25mg
    • +2 more
    • Dundee, Angus, United Kingdom
      University of Dundee, Ninewells Hospital and Medical School
    Jun 22, 2021

    Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Empagliflozin 25 MG
    • Enalapril Maleate 20 mg
    • (no location specified)
    May 9, 2022

    Aortic Valve Stenosis Trial in Strasbourg (Myocardium biopsy)

    Not yet recruiting
    • Aortic Valve Stenosis
    • Myocardium biopsy
    • Strasbourg, France
      Hôpitaux Universitaires de Strasbourg
    Apr 13, 2023

    Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)

    Completed
    Has Results
    • Pancreas Cancer
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Dec 20, 2022

    Non-alcoholic Fatty Liver Disease Trial in Kanazawa (Tofogliflozin, Glimepiride)

    Completed
    • Non-alcoholic Fatty Liver Disease
    • Kanazawa, Ishikawa, Japan
      Kanazawa University Graduate School of Medical Sciences
    Jun 30, 2021

    Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • Seoul, Korea, Republic of
      Yonsei University College of Medicine
    Aug 1, 2023

    Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))

    Not yet recruiting
    • Metabolic Associated Fatty Liver Disease
    • dapagliflozin (Forxiga)
    • (no location specified)
    Mar 13, 2023

    Heart Failure Trial in Denmark (Digital letter)

    Recruiting
    • Heart Failure
    • Digital letter
    • Copenhagen, Denmark
    • +4 more
    Jun 5, 2023